Skip to content

A prospective cohort study on the prevention and treatment of spastic paralysis after stroke using Shi's meridian needling method

A prospective cohort study on the prevention and treatment of spastic paralysis after stroke using Shi's meridian needling method

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088769
Enrollment
Unknown
Registered
2024-08-26
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post stroke spastic paralysis

Interventions

Exposed group:none

Sponsors

The First Affiliated Hospital of Tianjin University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: Those who meet the diagnostic criteria of Western medicine, traditional Chinese medicine, and spastic paralysis for this disease can be included in treatment 2. Meets the above diagnostic criteria, with decreased limb muscle strength and a muscle strength score of less than level 5 3. Within 6 months of stroke course 4. Age range from 35 to 80 years old 5. After treatment, the patient's condition remains stable, can cooperate with treatment, and can complete relevant functional assessments 6. Those who voluntarily participate and have signed an informed consent form

Exclusion criteria

Exclusion criteria: 1. Limb dysfunction caused by fractures, osteoporosis, arthritis, and other reasons 2. Patients with traumatic brain injury, aneurysm, neuroma, and arteriovenous malformation 3. Patients with severe damage to heart, liver, and kidney function in combination 4. Patients with extensive cerebral infarction, severe cerebral edema, and herniation

Design outcomes

Primary

MeasureTime frame
modified Ashworth scale;

Secondary

MeasureTime frame
Fugl-Meyer Assessment;Composite Spasticity Scale;Barthel index;National Institutes of Health ;AdverseDrugReaction;

Countries

China

Contacts

Public ContactLi Chen

The First Affiliated Hospital of Tianjin University of Chinese Medicine

lichen741206@sina.com+86 135 0210 1670

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026